
Urimas 0.4mg Tablet
Marketer
Mas Life Science
Salt Composition
Tamsulosin (0.4mg)
Overview Urimas 0.4mg Tablet
Tamsulosin 0.4mg tablets, an alpha-blocker medication, are prescribed for managing benign prostatic hyperplasia (BPH). This treatment alleviates urinary symptoms such as hesitancy, but it doesn't shrink the prostate gland. Always adhere to your physician's prescribed dosage and regimen. The medication can be taken with or without food, but consistency in timing is crucial. Swallow the tablet whole; avoid crushing or chewing. Discontinuing treatment prematurely, without medical consultation, may exacerbate symptoms. Complete the prescribed course for optimal results. Common side effects include lightheadedness, back discomfort, chest pain, altered ejaculation, and retrograde ejaculation. Report any persistent or troublesome side effects to your doctor immediately. Lifestyle adjustments can improve symptom control. Void your bladder promptly upon feeling the urge, but avoid straining. Limit or avoid caffeinated and alcoholic beverages in the evening and before sleep. Disclose all current medications to your doctor before commencing treatment. If cataract or glaucoma surgery is planned, inform your ophthalmologist about your Tamsulosin use. Individuals with liver impairment should exercise caution, maintaining regular follow-up appointments as directed by their doctor.
Primary Ingredients of Urimas 0.4mg Tablet
No text provided to rephrase.
Uses of Urimas 0.4mg Tablet
Managing benign prostatic enlargement
Major Benefits of Urimas 0.4mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.4mg Urimas tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Urimas 0.4mg Tablet:
- Chest pain
- Inflammation of the nose
- Dizziness
- Ejaculation disorder
- Headache
- Abdominal pain
- Back pain
- Nausea
- Infection
How to use Urimas 0.4mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Urimas 0.4mg tablets can be consumed with or without food; however, consistent timing is recommended.
How Urimas 0.4mg Tablet works:
Urimas 0.4mg tablets are alpha-adrenergic antagonists. Their mechanism of action involves relaxing the muscles controlling bladder outlet and prostate, thus facilitating easier urination. This promotes complete bladder emptying and lessens the frequency and urgency of urination associated with benign prostatic hyperplasia (BPH).
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Urimas 0.4mg tablets and alcohol can lead to significant sedation.
PregnancyCONSULT YOUR DOCTOR
Data on Urimas 0.4mg Tablet use in pregnancy are unavailable. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
The use of Urimas 0.4mg Tablet while breastfeeding is likely unsafe. Studies in humans indicate potential transfer to breast milk, posing a risk to the infant. This medication is not recommended for breastfeeding mothers.
DrivingSAFE
Driving ability is typically unaffected by Urimas 0.4mg tablets.
KidneySAFE IF PRESCRIBED
For individuals with kidney disease, Urimas 0.4mg tablets are considered safe, and no dosage modification is necessary. Nevertheless, data regarding Urimas 0.4mg tablet use in patients experiencing end-stage renal disease is limited. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.4mg Urimas tablets cautiously. Dosage modification of Urimas 0.4mg tablets may be necessary. Physician consultation is advised.
What if you forget to take Urimas 0.4mg Tablet :
Should you forget a Urimas 0.4mg Tablet dose, administer it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosage regimen. Avoid taking a double dose.
Facts to Know About Urimas 0.4mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Sulfamoyl Compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
